44 Wealth Management’s Labcorp LH Stock Holding History

44 Wealth Management’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,783	Closed	-$512K	–	205
2025 Q3	$512K	Sell	1,783 -3,041	-63%	-$815K	0.17%	138
2025 Q2	$1.27M	Sell	4,824 -36	-0.7%	-$8.77K	0.45%	76
2025 Q1	$1.13M	Sell	4,860 -90	-2%	-$21.8K	0.42%	83
2024 Q4	$1.14M	Sell	4,950 -304	-6%	-$69.7K	0.44%	76
2024 Q3	$1.16M	Buy	+5,254	New	+$1.15M	0.41%	80
2023 Q2	$1.08M	Buy	5,214 +453	+10%	+$87.9K	0.37%	68
2023 Q1	$938K	Buy	4,761 +171	+4%	+$35.2K	0.32%	74
2022 Q4	$928K	Buy	4,590 +421	+10%	+$82.3K	0.32%	77
2022 Q3	$734K	Buy	4,169 +1,864	+81%	+$382K	0.3%	83
2022 Q2	$464K	Buy	2,305 +18	+0.8%	+$3.84K	0.18%	109
2022 Q1	$518K	Buy	+2,287	New	+$538K	0.19%	110

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

44 Wealth Management's LH Position: Q4 2025 in Review

44 Wealth Management sold out of Labcorp (LH) in Q4 2025, closing a stake of 1,783 shares — an estimated $512K sold.

44 Wealth Management first reported a position in LH in Q1 2022 and held it in 11 quarters. The position peaked at $1.27M in Q2 2025. 1,030 funds tracked by Wall St. Rank hold LH as of Q4 2025.

44 Wealth Management reported no remaining Labcorp position as of Q4 2025 after selling out during the quarter.
44 Wealth Management sold 1,783 Labcorp shares in Q4 2025, an estimated $512K.
44 Wealth Management first reported a position in Labcorp in Q1 2022 and held it in 11 quarters.
44 Wealth Management's Labcorp position peaked at $1.27M in Q2 2025.
1,030 funds tracked by Wall St. Rank held Labcorp as of Q4 2025.

Based on 44 Wealth Management's 13F filing for Q4 2025, filed 9 Feb 2026.